How to keep finding those winners...

WeightWatchers' $106 Million Deal Turns into Your 174% Winner WeightWatchers, aka WW International Inc. (WW), is an American icon: Its weight-loss program has been a staple of cable TV commercials since the 1960s. But when it announced the acquisition of telehealth provider Sequence for $106 million in March, few understood an evolution was taking place, turning WeightWatchers from a diet company into a healthcare company. And it was destined to be a profitable evolution. Sequence gives WW access to a new digital market of prescription-weight-loss drugs, connecting people with medical doctors who can prescribe drugs like Ozempic and Wegovy. Wegovy and Ozempic are brand names for the same generic GLP-1 drug, semaglutide. The difference: Wegovy is specifically approved as a weight-loss treatment while Ozempic is approved for type 2 diabetes. Both are sold by Novo Nordisk (NVO). Those weight-loss drugs are big business. Here's The Wall Street Journal on the situation: “But because the majority of adult Americans are overweight—a trend that's on the rise in many other countries as well—investors and analysts are excited about these medications' huge potential for years to come, especially if more are covered by insurance. If analysts' outlooks for these drugs are correct, they could easily become multibillion-dollar blockbusters.” Just in 2022 alone: Ozempic sales totaled $8.56 billion. Wegovy sales totaled $900 million. RECOMMENDED LINK Hidden AI stock is secret key to ChatGPT (Trades for less than $5) One of the world's great stock experts just revealed details about an obscure AI stock that trades under a hidden name. The company is seeing surging sales on the technology needed to run powerful language models like ChatGPT. Click here for more details And the momentum is building in 2023: Ozempic sales reached $3.2 billion in the second quarter. Wegovy sales racked up $1.1 billion in the second quarter. Tapping into this new market has created a game-changing opportunity for WW International, as Wall Street had previously thrown this stock out as a has-been. But our friends at Derby City Insights, using proprietary consumer data from LikeFolio, saw something unfolding on Main Street that showed this was going to be bigger than most people could have anticipated. Immediate Data Equals a Big Investing Edge Real-time consumer insights revealed that WW International was gaining momentum with consumers under new leadership — outperforming other weight management services and home fitness companies in demand while maintaining high levels of Consumer Happiness. Also, on March 8, after seeing that Purchase Intent mentions — how many folks are buying or thinking about buying a service or product — Derby City Insights sent out a report about the start of a slight uptick it saw in Purchase Intent. It was fortuitous of what was to come. WW stock closed at $5.46 on March 8. Fast forward a few months to August 18, and WW opened at $9.62… a 76% gain in a little over five months. And for the members of LikeFolio Investor, it was an even bigger win. The stewards of the service — Andy and Landon Swan — alerted members in December 2022 about WW's profit potential. They issued a bullish LikeFolio Investor report on the stock in December, when it was trading near $3.70, and predicted that WW shares could climb by more than 100% within the next two years. It was a bold prediction but they stood by it, knowing the power of consumer sentiment data in predicting future moves in the stock market. And the projection of the triple-digit opportunity happened in a fraction of the time. RECOMMENDED LINK 16,000 Financial Advisors Will Use A.I. for Stock Picking, But You Don't Have to Wait According to The Ascent, in a survey of American adults, 54% of respondents had asked ChatGPT for financial advice. Traditional financial service companies like Morgan Stanley are already developing A.I. bots for over 16,000 of its advisors that will give instant answers – and their clients a leg up on everyone else. But the thing is... you don't have to wait for more developments in A.I. for the chance to start making money. We've been at the forefront of A.I. stock investing, and we want to show you something so you aren't left in the dark anymore... Check out this breakthrough A.I. forecasting system that can predict stock prices with remarkable accuracy. LikeFolio Investor members were rewarded last week when Andy and Landon sent instructions to cash out — with many having had the opportunity to bag a 174% gain. But selling that position doesn't mean the brothers are turning sour on this industry. Not in the slightest. They are looking at the next winners in the weight loss space and found one stock trading for less than $7, projecting it will be another triple-digit winner. Current members can access (friendly reminder that you must be logged in to view) that latest update here. For those interested in learning more so you can have these LikeFolio Investor trade alerts hit your inbox as soon as they're released, all you have to do is go here now. Enjoy your Monday, Keith Kaplan CEO, TradeSmith Get Instant Access Click to read these free reports and automatically sign up for research throughout the week. 25 Doomed Blue Chip Stocks 3 Stocks That Could Triple This Year Customer Support: 866.385.2076 |  support@tradesmith.com Request Customer Service ©TradeSmith, LLC. All Rights Reserved. You may not reproduce, modify, copy, sell, publish, distribute, display or otherwise use any portion of the content without the prior written consent of TradeSmith. TradeSmith is not registered as an investment adviser and operates under the publishers' exemption of the Investment Advisers Act of 1940. The investments and strategies discussed in TradeSmith's content do not constitute personalized investment advice. Any trading or investment decisions you take are in reliance on your own analysis and judgment and not in reliance on TradeSmith. There are risks inherent in investing and past investment performance is not indicative of future results. TradeSmith P.O. Box 340087 Tampa, FL 33694 Terms of Use Privacy Policy To unsubscribe or change your email preferences, please click here.